| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.8M | — | -33.7% |
| Cost of Revenue | $9.5M | — | -36.9% |
| Gross Profit | $6.3M | — | -28.2% |
| R&D Expense | $8.7M | — | +2.2% |
| SG&A Expense | $18.1M | — | +14.6% |
| Operating Income | -$24.6M | — | +3.4% |
| Interest Expense | $0 | — | -100.0% |
| Pre-tax Income | -$25.8M | — | -24.8% |
| Income Tax | $55K | — | +1016.7% |
| Net Income | -$25.8M | — | -25.1% |
| EPS (Basic) | -$0.78 | — | -1.3% |
| EPS (Diluted) | -$0.78 | — | -1.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.0M | -35.3% | -55.3% |
| Short-term Investments | $33.4M | -41.4% | — |
| Accounts Receivable | $7.0M | +68.5% | -30.8% |
| Current Assets | $64.4M | -31.3% | -40.5% |
| Total Assets | $182.9M | -13.3% | -12.4% |
| Current Liabilities | $68.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$26.2M | — | -211.0% |
| Capital Expenditures | $8.0M | — | -10.4% |
| Investing Cash Flow | $16.0M | — | +279.8% |
| Financing Cash Flow | $21K | — | -99.9% |
| Free Cash Flow | -$34.2M | — | -97.2% |
| -57.6% |
| Total Liabilities | $91.7M | -6.5% | -54.9% |
| Stockholders' Equity | $91.2M | -19.2% | +1541.9% |